Haptoglobin polymorphism and diabetic retinopathy in Brazilian patients

Diabetes Research and Clinical Practice

Volumn 77, Issue 3, 2007, Pages 385-388

  Wobeto, Vânia P A ^a   Rosim, Endrigo T ^a   Melo, Mônica B ^b   Calliari, Luís Eduardo P ^c   Sonati, Maria de Fátima ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Molecular Medicine Laboratory   (Brazil)

^c IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

Author keywords

Brazilian population; Diabetes mellitus; Diabetic retinopathy; Genetic polymorphisms; Haptoglobin genotypes

Indexed keywords

HAPTOGLOBIN; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BRAZIL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BRAZIL; CASE-CONTROL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; GENE FREQUENCY; GENOTYPE; HAPTOGLOBINS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34547697147     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.12.018     Document Type: Article

References (16)

1. Chiellini C., Bertacca A., Novelli S.E., Gorgun C.Z., Ciccarone A., Giordano A., et al. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFalpha. J. Cell. Physiol. 190 (2002) 251-258
2. Arredouani M.S., Kasran A., Vanoirbeek J.A., Berger F.G., Baumann H., and Ceuppens J.L. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 114 (2005) 263-271
3. Langlois M.R., and Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42 (1996) 1589-1600
4. Sadrzadeh S.M., and Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am. J. Clin. Pathol. 121 Suppl. (2004) S97-S104
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab. Care 29 Suppl. (2006) S43-S48
6. Giugliano D., and Ceriello A. Oxidative stress and diabetic vascular complications. Diab. Care 19 (1996) 257-263
7. Nakhoul F.M., Zoabi R., Kauter Y., Zoabi M., Skorecki K., Hochberg I., et al. Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44 (2001) 602-604
8. Nakhoul F.M., Marsh S., Hochberg I., Leibu R., Miller B.P., and Levy A.P. Haptoglobin genotype as a risk factor for diabetic retinopathy. JAMA 284 (2002) 1244-1245
9. Fong D.S., Aiello L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., et al. Diabetic retinopathy. Diab. Care 26 Suppl. (2003) S99-S102
10. Malerbi D.A., and Franco L.J. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. The Brazilian Cooperative Group on the Study of Diabetes Prevalence. Diab. Care 15 (1992) 1509-1516
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab. Care 27 (2004) 5-10
12. Zaccariotto T.R., Rosim E.T., Melo D., Garcia P.M., Munhoz R.R., Aoki F.H., et al. Haptoglobin polymorphism in a HIV-1 seropositive Brazilian population. J. Clin. Pathol. 59 (2006) 550-553
13. Yano A., Yamamoto Y., Miyaishi S., and Ishizu H. Haptoglobin Genotyping by Allele-Specific Polimerase Chain Reaction Amplification. Acta Med. Okayama 52 (1998) 173-181
14. Langlois M.R., Martin M.E., Boelaert J.R., Beaumont C., Taes Y.E., De Buyzere M.L., et al. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin. Chem. 46 (2000) 1619-1625
15. Levy A.P., Roguin A., Hochberg I., Herer P., Marsh S., Nakhoul F.M., et al. Haptoglobin phenotype and vascular complications in patients with diabetes. N. Engl. J. Med. 13 (2000) 969-970
16. Koda Y., Yamagishi S., Amano S., Okamoto T., Inagaki Y., Yamada K., et al. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients. Diabetología 45 (2002) 1039-1040